Does the International Flavors and Fragrances (IFF) Discount Rate Open an Opportunity?
Heartland Advisorsinvestment management company, released the second quarter 2026 investor prospectus for “Heartland Mid Cap Value Fund”. A copy can be downloaded here. Mid-cap stocks rose sharply in the second quarter, driven by AI beneficiaries, especially in technology. The fund returned 9.90% for the quarter, compared to the Russell Midcap® Value Index’s return of 13.40%. The underperformance was attributed to poor stock selection despite Tech being one of the top absolute return contributors. In a difficult situation, the Fund remains focused on its systematic approach to safety selection. In addition, you can check the 5 best things of the Fund to decide the best choice in 2026.
In its Q2 2026 investor letter, Heartland Mid Cap Value Fund highlighted International Flavor & Fragrances Inc. (NYSE:IFF). International Flavor & Fragrances Inc. (NYSE:IFF) is a specialty chemical company that makes products across food, beverage, health and life sciences, fragrance, pharma solutions, and closely related products. On July 14, 2026, International Flavor & Fragrances Inc. (NYSE:IFF) closed at $74.67 per share, representing a market capitalization of $19.06 billion. International Flavor & Fragrances Inc. (NYSE:IFF) posted a one-month return of -1.81%, while its shares gained 0.61% over the past 52 weeks.
Heartland Mid Cap Value Fund says the following about International Flavor & Fragrances Inc. (NYSE:IFF) in its Q2 2026 investor update:
“Materials. Deep value capture is new International Flavor & Fragrances Inc. (NYSE:IFF), a specialty ingredient manufacturer that sells flavors, fragrances, and enzymes to food, beverage, personal care, household products, and human health product manufacturers. This is an example of identifying a self-help opportunity through bottom-up research.
For more than two years, management has worked to adjust IFF’s portfolio and operations to focus on high-income businesses that enjoy superior market share, better pricing power, attractive growth, and improved capital allocation flexibility. The strategy follows years of misguided budget allocations by previous administrations. Today, IFF’s income is divided equally into three categories. Flavor accounts for 30% of revenue, Health & Biosciences generates 37%, and Fragrance contributes 32%. In the Fragrance category, IFF’s pioneering of integrated fragrance technology has secured its leadership in textile care, a position that is now expanding into fragrance enhancers, shampoos, and body washes.
Driven to improve growth, margins, and free cash flow, we believe IFF is well positioned to operate alongside industry leader Givaudan. But while Givaudan trades at 19.14X forward EBITDA, IFF trades at a discount of just 12.23X. Underscoring management’s confidence in this closing of the equity gap, the company recently launched its first share buyback program in six years.”
